RNA metabolism is the primary target of formamide in vivo

The synthesis, processing and function of coding and non-coding RNA molecules and their interacting proteins has been the focus of a great deal of research that has boosted our understanding of key molecular pathways that underlie higher order events such as cell cycle control, development, innate immune response and the occurrence of genetic diseases. In this study, we have found that formamide preferentially weakens RNA related processes in vivo. Using a non-essential Schizosaccharomyces pombe gene deletion collection, we identify deleted loci that make cells sensitive to formamide. Sensitive deletions are significantly enriched in genes involved in RNA metabolism. Accordingly, we find that previously known temperature-sensitive splicing mutants become lethal in the presence of the drug under permissive temperature. Furthermore, in a wild type background, splicing efficiency is decreased and R-loop formation is increased in the presence of formamide. In addition, we have also isolated 35 formamide-sensitive mutants, many of which display remarkable morphology and cell cycle defects potentially unveiling new players in the regulation of these processes. We conclude that formamide preferentially targets RNA related processes in vivo, probably by relaxing RNA secondary structures and/or RNA-protein interactions, and can be used as an effective tool to characterize these processes

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

NUEVAS ESTRATEGIAS PARA LA ELABORACIÓN DE TFG EN INGLÉS: TUTORÍAS ENTRE IGUALES Y MINI-VÍDEOS DOCENTES

Writing academic texts in English is closely related to the linguistic competence that university students need to develop (B1 level as a minimum linguistic requirement prior to their graduation). This competence entails an improvement of their future employability (both at the national and international levels), their communicative competences in a second language (L2), and obviously also the possibility that the results derived from their academic projects spill across national boundaries. This innovation project arises as the evolution of a previous innovation strategy, approved and implemented at the University of Córdoba (“La tutoría piramidal como estrategia para el diseño y desarrollo del trabajo final de grado en educación”, 2015-2-6011), whose results allowed the identification of the weaknesses that we aim to focus on during the development of this project. The final objective is to teach university students how to write their end-of-degree dissertations in English. At the same time teachers of the UCO also participate in a series of seminars to know different techniques about how to review these projects that are written in a language different from their mother tongue or main language. The methodology of this project is based on participative seminars, as well as on the development of resources, where students (mentors and mentees) and teachers (mentors and mentees) collaborate towards a common objective: writing and reviewing end-of-degree dissertations, mainly written in English. Among these resources, it can be highlighted the design and elaboration of teaching mini-videos, with the participation of the teachers involved in the project, as well as the mentor students, in order to explain the key aspects to be considered when writing an end-of-degree dissertation.La redacción de textos académicos en inglés está íntimamente relacionada con la competencia lingüística que el alumnado universitario ha de desarrollar (B1 como requisito lingüístico mínimo previo a su graduación) y que, de manera lógica, está encadenada a la mejora de su empleabilidad (tanto a niveles nacionales como internacionales), de sus competencias comunicativas en segunda lengua y, por supuesto, la posibilidad de que los resultados de su trabajo académico trasciendan fronteras. El proyecto que aquí se presenta surge como evolución de un proyecto de innovación docente anterior, aprobado e implementado en la UCO (“La tutoría piramidal como estrategia para el diseño y desarrollo del trabajo final de grado en educación”, 2015-2-6011), y cuyo resultado ha permitido identificar la necesidad que con esta propuesta pretendemos cubrir. El objetivo final de este proyecto es enseñar al alumnado universitario a redactar sus TFG en inglés, al tiempo que el profesorado también participa en los seminarios, en los que se abordan también técnicas que faciliten la corrección de estos trabajos que se redactan en una lengua no materna o principal. La metodología se basa en seminarios participativos, así como en la elaboración de recursos, en los que alumnado (tutores y tutorizados) y profesorado (tutores y tutorizados) colaborarán para la consecución final del objetivo: la redacción y corrección de TFG, principalmente en lengua inglesa. Entre estos recursos, destacamos el diseño y la elaboración de minivídeos docentes modulares con la participación del profesorado implicado en el proyecto, así como del alumnado mentor, para explicar los aspectos clave de la elaboración de un TFG

On the mathematical modelling and data assimilation for air pollution assessment in the Tropical Andes

Air pollution assessment in the Tropical Andes requires a multidisciplinary approach. This can be supported from the understanding of the underlying biological dynamics and atmospheric behavior, to the mathematical approach for the proper use of all available information. This review paper touches on several aspects in which mathematical models can help to solve challenging problems regarding air pollution in reviewing the state-of-the-art at the global level and assessing the corresponding state of development as applied to the Tropical Andes. We address the complexities and challenges that modelling atmospheric dynamics in a mega-diverse region with abrupt topography entails. Understanding the relevance of monitoring and facing the problems of data scarcity, we call attention to the usefulness of data assimilation for uncertainty reduction, and how these techniques could help tackle the scarcity of regional monitoring networks to accelerate the implementation and development of modelling systems for air quality in the Tropical Andes. Finally, we suggest a cyberphysical framework for decision-making processes based on the data assimilation of chemical transport models, the forecast of scenarios, and their use in regulation and policy making. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature

Screening for HTLV-1 infection should be expanded in Europe

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is spreading globally at an uncertain speed. Sexual, mother-to-child, and parenteral exposure are the major transmission routes. Neither vaccines nor antivirals have been developed to confront HTLV-1, despite infecting over 10 million people globally and causing life-threatening illnesses in 10% of carriers. It is time to place this long-neglected disease firmly into the 2030 elimination agenda. Current evidence supports once-in-life testing for HTLV-1, as recommended for HIV, hepatitis B and C, along with targeted screening of pregnant women, blood donors, and people who attended clinics for sexually transmitted infections (STIs). Similar targeted screening strategies are already being performed for Chagas disease in some Western countries in persons from Latin America. Given the high risk of rapid-onset HTLV-1-associated myelopathy, universal screening of solid organ donors is warranted. To minimize organ wastage, however, the specificity of HTLV screening tests must be improved. HTLV screening of organ donors in Europe has become mandatory in Spain and the United Kingdom. The advent of HTLV point-of-care kits would facilitate testing. Finally, increasing awareness of HTLV-1 will help those living with HTLV-1 to be tested, clinically monitored, and informed about transmission-preventive measures